Delivery Order SPE2DB22D1052-SPE2DB25FU8LY
Award Date 2/6/25
Potential Completion Date 2/28/25
Potential Value $9.8K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $8,133.50 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 1,500 units of the product KEDRAB (10 ML vial). This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical for the provision of a wide range of pharmaceutical products and medical supplies to support military...
- The U.S. government awarded a $3,248.76 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 1,500 units of KEDRAB 10 mL vials. This contract was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. Amerisourcebergen has an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for delivering a range of medical commodities to support...
- This is a $4,873.11 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 1,500 units of the drug KEDRAB in 10 ml vials, with a period of performance through March 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $3,361.04 contract is for the delivery of 1,500 units of the 10 mL vial product KEDRAB, with a completion date of January 22, 2025. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as the primary vehicle for providing a...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $1,945.62 order is for KEDRAB, a 300 unit/2 ml vial pharmaceutical product, with a completion date of March 11, 2024. This delivery order falls under Amerisourcebergen Drug Corp's existing indefinite delivery contract with DLA Troop Support Medical, which has a potential value of up to...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $8,121.85 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 1,500 units of the pharmaceutical product KEDRAB (10 ml vials). The contract has a firm fixed-price pricing type and an ultimate completion date of July 11, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 31,...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $3,248.74 contract is for the delivery of 1,500 units of the pharmaceutical product KEDRAB (10 ML vial). The delivery order falls under a larger indefinite-delivery/indefinite-quantity (IDIQ) contract valued at up to $999,999,999 through December 2025, which provides a wide range of medical commodities to support military treatment...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of KEDRAB 300 UNIT/2 ML VIAL 2ML. The contract has a firm fixed price of $3,325.30 and a completion date of July 15, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 1,500 units of the medication KEDRAB 10 ML vial. The contract has a ceiling value of $6,506.80 and a period of performance ending on June 12, 2025. The contract is not set aside for any small business or socioeconomic program. AmerisourceBergen Drug Corp is a for-profit corporate entity that serves as a critical supplier...
- This federal contract award, valued at $3,248.76, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 1,500 units of the drug KEDRAB, a 10 ml vial, with an ultimate completion date of August 28, 2024. This is a firm-fixed-price delivery order contract, and there is no set-aside designation. Amerisourcebergen, through its extensive supply chain network,...